#MedicapHealthcare #IPO #DRHP #SEBI #PharmaPackaging #EuroHeadCaps #IndianMarket #FreshIssue #Healthcare #CapitalMarket
Chandigarh— Medicap Healthcare Limited, a key player in the Indian pharmaceutical packaging sector, has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to launch an Initial Public Offering (IPO). The IPO is a Fresh Issue aggregating up to ₹2,400 million (₹240 Crore), with no Offer-For-Sale component, indicating the company’s focus on raising capital for future growth.
Company Profile and Market Dominance
Medicap Healthcare specializes in producing pharmaceutical closures, including Euro Head caps and bottle preforms. It operates from a state-of-the-art 6,732 sq. mt. manufacturing facility located at Manjusar, Vadodara, Gujarat.
The company holds a dominant position in its niche:
- Domestic Market Share: Over of the domestic market for Euro Head caps.
- Global Presence: Approximately of the global market share for Euro Head caps.
- Revenue Mix (FY2025): from domestic sales and from exports to 14 countries.
- Manufacturing Capacity: Total annual installed capacity is approximately 751 million units (including 389 million Euro Head caps and 149 million bottle preforms).
Medicap’s manufacturing adheres to stringent quality and regulatory standards, holding ISO 9001:2015, ISO 14001:2015 certifications, and complying with Good Manufacturing Practices (GMP) and Drug Master File (DMF) guidelines.
Objects of the Issue
The proceeds from the ₹240 Crore fresh issue are strategically earmarked for capacity expansion, debt reduction, and general corporate purposes, aiming to bolster the company’s financial stability and operational scale. The key uses are:
The strategic investment in plant and machinery, aggregating ₹74.37 Crore, is aimed at enhancing the existing manufacturing capabilities to meet growing domestic and export demand. Furthermore, the total allocation of ₹85.70 Crore towards debt repayment (including the investment in subsidiary KASR Healthcare Private Limited) will reduce the company’s financial leverage.
Aryaman Financial Services Limited has been appointed as the sole Book Running Lead Manager for the Issue.
#MedicapHealthcare #IPO #DRHP #SEBI #PharmaPackaging #EuroHeadCaps #IndianMarket #FreshIssue #Healthcare #CapitalMarket
